Comments
Loading...

Ionis Pharmaceuticals

IONSNASDAQ
Logo brought to you by Benzinga Data
$42.36
0.852.05%
At Close: -
$42.36
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$88.00
Lowest Price Target1
$27.00
Consensus Price Target1
$58.88

Ionis Pharmaceuticals (NASDAQ:IONS) Stock, Analyst Ratings, Price Targets, Forecasts

Ionis Pharmaceuticals Inc has a consensus price target of $58.88 based on the ratings of 28 analysts. The high is $88 issued by Wells Fargo on May 4, 2023. The low is $27 issued by SVB Leerink on February 23, 2023. The 3 most-recent analyst ratings were released by JP Morgan, Guggenheim, and Goldman Sachs on August 26, 2024, August 2, 2024, and August 2, 2024, respectively. With an average price target of $54 between JP Morgan, Guggenheim, and Goldman Sachs, there's an implied 27.48% upside for Ionis Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Apr
1
May
1
Jun
1
Jul
3
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Guggenheim
Goldman Sachs
Barclays
Needham

1calculated from analyst ratings

Analyst Ratings for Ionis Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Ionis Pharmaceuticals (IONS) stock?

A

The latest price target for Ionis Pharmaceuticals (NASDAQ:IONS) was reported by JP Morgan on August 26, 2024. The analyst firm set a price target for $55.00 expecting IONS to rise to within 12 months (a possible 29.84% upside). 38 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ionis Pharmaceuticals (IONS)?

A

The latest analyst rating for Ionis Pharmaceuticals (NASDAQ:IONS) was provided by JP Morgan, and Ionis Pharmaceuticals maintained their neutral rating.

Q

When was the last upgrade for Ionis Pharmaceuticals (IONS)?

A

The last upgrade for Ionis Pharmaceuticals Inc happened on July 24, 2024 when Leerink Partners raised their price target to $62. Leerink Partners previously had a market perform for Ionis Pharmaceuticals Inc.

Q

When was the last downgrade for Ionis Pharmaceuticals (IONS)?

A

The last downgrade for Ionis Pharmaceuticals Inc happened on August 2, 2024 when BMO Capital changed their price target from $67 to $60 for Ionis Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Ionis Pharmaceuticals (IONS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ionis Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ionis Pharmaceuticals was filed on August 26, 2024 so you should expect the next rating to be made available sometime around August 26, 2025.

Q

Is the Analyst Rating Ionis Pharmaceuticals (IONS) correct?

A

While ratings are subjective and will change, the latest Ionis Pharmaceuticals (IONS) rating was a maintained with a price target of $50.00 to $55.00. The current price Ionis Pharmaceuticals (IONS) is trading at is $42.36, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch